February 26, 2024
You are here:  Home  >  Banking & Finance  >  Current Article

Amgen shares up amid optimism over experimental weight-loss drug


Amgen shares climbed nearly 6% on Oct. 11, their biggest single-day gain in seven months, behind a rating bump from a Morgan Stanley analyst, and continued to climb more gradually in the days after. Thousand Oaks-based Amgen, one of the largest biotechnology companies in the world, closed at $245.44 on Oct. 11, up from $232.15…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.